D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 77 Citations 16,025 447 World Ranking 13624 National Ranking 709

Overview

What is he best known for?

The fields of study Dirk Reinhardt is best known for:

  • Gene
  • Cancer
  • Enzyme

Dirk Reinhardt combines Internal medicine and Gastroenterology in his studies. His work blends Gastroenterology and Internal medicine studies together. In his research, Dirk Reinhardt performs multidisciplinary study on Gene and Cell biology. Dirk Reinhardt integrates Cell biology with Gene in his research. Dirk Reinhardt integrates many fields in his works, including Myeloid leukemia and Leukemia. In his works, Dirk Reinhardt performs multidisciplinary study on Leukemia and Cancer research. As part of his studies on Cancer research, he often connects relevant subjects like Myeloid. As part of his studies on Myeloid, he often connects relevant subjects like Immunology. His research links Myeloid leukemia with Immunology.

His most cited work include:

  • Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. (421 citations)
  • Traffic-related air pollution and respiratory health during the first 2 yrs of life (262 citations)
  • Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia (226 citations)

What are the main themes of his work throughout his whole career to date

His study on Internal medicine is intertwined with other disciplines of science such as Endocrinology, Oncology, Gastroenterology, Pediatrics and Surgery. Dirk Reinhardt performs integrative study on Endocrinology and Internal medicine. His Genetics research spans across into areas like Gene, Cancer research and Immunology. He performs multidisciplinary study in the fields of Gene and Genetics via his papers. His Cancer research study frequently draws parallels with other fields, such as Myeloid leukemia. His work on Myeloid leukemia expands to the thematically related Immunology. Dirk Reinhardt undertakes multidisciplinary investigations into Leukemia and Myeloid in his work. While working on this project, he studies both Myeloid and Leukemia.

Dirk Reinhardt most often published in these fields:

  • Internal medicine (74.81%)
  • Genetics (31.11%)
  • Gene (26.67%)

What were the highlights of his more recent work (between 2013-2020)?

  • Gene (54.55%)
  • Genetics (54.55%)
  • Cancer research (45.45%)

In recent works Dirk Reinhardt was focusing on the following fields of study:

Dirk Reinhardt conducts interdisciplinary study in the fields of Gene and Chromosomal translocation through his works. His work on Cell growth expands to the thematically related Genetics. In his research, he undertakes multidisciplinary study on Cell growth and Gene. As part of his studies on Cancer research, Dirk Reinhardt often connects relevant areas like Myeloid. He applies his multidisciplinary studies on Myeloid and Leukemia in his research. He performs multidisciplinary study in the fields of Leukemia and Myeloid leukemia via his papers. He combines topics linked to Cancer research with his work on Myeloid leukemia. His research is interdisciplinary, bridging the disciplines of Milk allergy and Immunology. He performs integrative Milk allergy and Food allergy research in his work.

Between 2013 and 2020, his most popular works were:

  • Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy (101 citations)
  • miR-9 is a tumor suppressor in pediatric AML with t(8;21) (69 citations)
  • miR-139-5p controls translation in myeloid leukemia through EIF4G2 (46 citations)

In his most recent research, the most cited works focused on:

  • Gene
  • Cancer
  • Apoptosis

Dirk Reinhardt combines Gene and Cell growth in his research. He frequently studies issues relating to Genetics and Cell growth. His research on Genetics often connects related topics like Suppressor. His Suppressor study frequently draws connections between adjacent fields such as Gene. Dirk Reinhardt integrates many fields in his works, including Leukemia and Cancer research. His research ties Myeloid leukemia and Cancer research together. His Myeloid leukemia study frequently links to related topics such as Immunology. In most of his Immunology studies, his work intersects topics such as Myeloid. In his research, he undertakes multidisciplinary study on Myeloid and Leukemia.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

Ursula Creutzig;Marry M. van den Heuvel-Eibrink;Brenda Gibson;Michael N. Dworzak.
Blood (2012)

554 Citations

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann.
Blood (2009)

431 Citations

Clinical implications of FLT3 mutations in pediatric AML

Soheil Meshinchi;Todd A. Alonzo;Derek L. Stirewalt;Michel Zwaan.
Blood (2006)

428 Citations

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.

Ursula Creutzig;M. Zimmermann;J. Ritter;D. Reinhardt.
Leukemia (2005)

313 Citations

Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

B F Goemans;Ch M Zwaan;Ch M Zwaan;M Miller;M Zimmermann.
Leukemia (2005)

287 Citations

Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

C. Michel Zwaan;Edward A. Kolb;Dirk Reinhardt;Jonas Abrahamsson.
Journal of Clinical Oncology (2015)

275 Citations

Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

Jan-Henning Klusmann;Ursula Creutzig;Martin Zimmermann;Michael Dworzak.
Blood (2008)

270 Citations

Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98

Ursula Creutzig;Martin Zimmermann;Dirk Reinhardt;Michael Dworzak.
Journal of Clinical Oncology (2004)

269 Citations

Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98

Christine von Neuhoff;Dirk Reinhardt;Annette Sander;Martin Zimmermann.
Journal of Clinical Oncology (2010)

267 Citations

Improved Treatment Results in High-Risk Pediatric Acute Myeloid Leukemia Patients After Intensification With High-Dose Cytarabine and Mitoxantrone: Results of Study Acute Myeloid Leukemia–Berlin-Frankfurt-Münster 93

U Creutzig;J Ritter;M Zimmermann;D Reinhardt.
Journal of Clinical Oncology (2001)

263 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Dirk Reinhardt

Todd A. Alonzo

Todd A. Alonzo

University of Southern California

Publications: 115

Ching-Hon Pui

Ching-Hon Pui

St. Jude Children's Research Hospital

Publications: 85

Raul C. Ribeiro

Raul C. Ribeiro

St. Jude Children's Research Hospital

Publications: 75

Jeffrey E. Rubnitz

Jeffrey E. Rubnitz

St. Jude Children's Research Hospital

Publications: 68

Henrik Hasle

Henrik Hasle

Aarhus University Hospital

Publications: 63

Lillian Sung

Lillian Sung

University of Toronto

Publications: 61

Susana C. Raimondi

Susana C. Raimondi

St. Jude Children's Research Hospital

Publications: 60

Gertjan J. L. Kaspers

Gertjan J. L. Kaspers

Amsterdam UMC

Publications: 49

Yasuhide Hayashi

Yasuhide Hayashi

Gunma Children's Medical Center

Publications: 45

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 45

Franco Locatelli

Franco Locatelli

Bambino Gesù Children's Hospital

Publications: 44

Rolf Marschalek

Rolf Marschalek

Goethe University Frankfurt

Publications: 44

Shai Izraeli

Shai Izraeli

Tel Aviv University

Publications: 42

Rob Pieters

Rob Pieters

Princess Maxima Center for Pediatric Oncology

Publications: 41

Andrea Pession

Andrea Pession

University of Bologna

Publications: 38

Torsten Haferlach

Torsten Haferlach

MLL Munich Leukemia Laboratory

Publications: 35

Trending Scientists

Hang Li

Hang Li

ByteDance

XiaoFeng Wang

XiaoFeng Wang

Indiana University

Donatella Sciuto

Donatella Sciuto

Polytechnic University of Milan

Georges Kaddoum

Georges Kaddoum

École de Technologie Supérieure

Kenneth R. Foster

Kenneth R. Foster

University of Pennsylvania

Kenneth J. Balkus

Kenneth J. Balkus

The University of Texas at Dallas

John I. Nurnberger

John I. Nurnberger

Indiana University

Amy L. Toth

Amy L. Toth

Iowa State University

Shigeru Yanagi

Shigeru Yanagi

Tokyo University of Pharmacy and Life Sciences

Soo Young Choi

Soo Young Choi

Hallym University

Jorge L. Benach

Jorge L. Benach

Stony Brook University

Klaus Früh

Klaus Früh

Oregon Health & Science University

Andrea Raballo

Andrea Raballo

University of Perugia

Dario Maestripieri

Dario Maestripieri

University of Chicago

Martin R. Turner

Martin R. Turner

University of Oxford

Markus Büttiker

Markus Büttiker

University of Geneva

Something went wrong. Please try again later.